72 related articles for article (PubMed ID: 11252980)
1. [Type 2 diabetes: what therapeutic strategy?].
Grimaldi A; Hartemann-Heurtier A
Presse Med; 2001 Feb; 30(6):288-97. PubMed ID: 11252980
[TBL] [Abstract][Full Text] [Related]
2. [Optimal therapeutic strategy in type 2 diabetes mellitus].
Scherbaum WA; Nitschmann S
Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
[No Abstract] [Full Text] [Related]
3. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of diabetes in metabolic syndrome].
Pelikánova T
Vnitr Lek; 2009; 55(7-8):637-45. PubMed ID: 19731868
[TBL] [Abstract][Full Text] [Related]
5. [New treatment strategies for type-2 diabetes?].
Halimi S
Presse Med; 2005 Oct; 34(18):1287-92. PubMed ID: 16269991
[TBL] [Abstract][Full Text] [Related]
6. New frontiers in the management of type 2 diabetes.
Mudaliar S
Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
8. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
Ross SA; Zinman B; Campos RV; Strack T;
Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
[TBL] [Abstract][Full Text] [Related]
10. [Arterial hypertension and type 2 diabetes].
Scheen AJ; Estrella F; Weekers L
Rev Med Liege; 1999 Oct; 54(10):789-95. PubMed ID: 10605312
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes in primary care in belgium: need for structured shared care.
Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
[TBL] [Abstract][Full Text] [Related]
12. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
Machoy M
Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
[TBL] [Abstract][Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
[TBL] [Abstract][Full Text] [Related]
15. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
[TBL] [Abstract][Full Text] [Related]
16. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
17. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
Wolffenbuttel BH; Heine RJ
Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
[TBL] [Abstract][Full Text] [Related]
18. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
19. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
Yeap BB
Aust Fam Physician; 2007 Jul; 36(7):549-53. PubMed ID: 17619673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
